Clinical trial
Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction: Mechanisms of Multi-target Anti-inflammatory Action
NCT02544087 is registered in ClinicalTrials.gov with Yunling Zhang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction: Mechanisms of Multi-target Anti-inflammatory Action
- Lead sponsor
- Yunling Zhang
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2015
- Completion date
- April 30, 2018
- Enrollment
- 120 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.